These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24817035)

  • 21. INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions.
    Shin N; Covington M; Bian D; Zhuo J; Bowman K; Li Y; Soloviev M; Qian DQ; Feldman P; Leffet L; He X; He Wang K; Krug K; Bell D; Czerniak P; Hu Z; Zhao H; Zhang J; Yeleswaram S; Yao W; Newton R; Scherle P
    Eur J Pharmacol; 2012 Jan; 675(1-3):47-56. PubMed ID: 22155710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double dose of levocetirizine leads to better control of histamine-induced flare, wheal and itch in healthy donors.
    Tanizaki H; Nakamizo S; Nakahigashi K; Miyachi Y; Kabashima K
    Pharmacology; 2013; 92(1-2):71-4. PubMed ID: 23942038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Kłos K; Kruszewski J; Kruszewski R; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
    Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
    Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus.
    Dunford PJ; Williams KN; Desai PJ; Karlsson L; McQueen D; Thurmond RL
    J Allergy Clin Immunol; 2007 Jan; 119(1):176-83. PubMed ID: 17208599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
    Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
    Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.
    Savall BM; Chavez F; Tays K; Dunford PJ; Cowden JM; Hack MD; Wolin RL; Thurmond RL; Edwards JP
    J Med Chem; 2014 Mar; 57(6):2429-39. PubMed ID: 24495018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
    Leroy T; van Neste D
    Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new generation of anti-histamines: Histamine H4 receptor antagonists on their way to the clinic.
    Engelhardt H; Smits RA; Leurs R; Haaksma E; de Esch IJ
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):628-43. PubMed ID: 19736622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist.
    Yamaura K; Oda M; Suwa E; Suzuki M; Sato H; Ueno K
    J Toxicol Sci; 2009 Oct; 34(4):427-31. PubMed ID: 19652466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
    Berkowitz RB; Dockhorn R; Lockey R; Findlay S; Howland WC; Mitchell DQ; Woehler T
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of antihistaminic activity of cetirizine by nimesulide.
    Rewari S; Gupta U
    J Assoc Physicians India; 1999 Apr; 47(4):389-92. PubMed ID: 10778521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects.
    Spiegelstein O; Stevens J; Van Gerven J; Nathan PJ; Maynard JP; Mayleben DW; Hellriegel E; Yang R
    J Psychopharmacol; 2016 Oct; 30(10):983-93. PubMed ID: 27222271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
    Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
    J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
    Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
    J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
    Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH; Briscoe M; Widlitz MD
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of the histamine H
    Werfel T; Layton G; Yeadon M; Whitlock L; Osterloh I; Jimenez P; Liu W; Lynch V; Asher A; Tsianakas A; Purkins L
    J Allergy Clin Immunol; 2019 May; 143(5):1830-1837.e4. PubMed ID: 30414855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial.
    Shohrati M; Davoudi SM; Keshavarz S; Sadr B; Tajik A
    Cutan Ocul Toxicol; 2007; 26(3):249-55. PubMed ID: 17687689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.